DramaQueenLucy
3-3-2008, 8:33 PM
Do You Suffer from Menstrual Migraines?
We are participating in a clinical research study evaluating the investigational form of a marketed drug compared to placebo in the treatment of menstrual migraine headaches. If you suffer from moderate to severe menstrual migraines that start with a mild pain phase, you may qualify.
To be considered for participation in this research study, you must be between the ages of 18 and 65, have had a menstrual migraine in at least 2 of the 3 premenstrual periods prior to screening, and be otherwise generally healthy. Medical staff at my site will review additional criteria with you to determine if you are eligible.
If you are eligible and decide to participate, you can expect 2 office visits: the Screening visit and the Final visit to occur either after the treatment of a single migraine attack or within 12 weeks of randomization if a headache has not been treated. All study participants will be instructed to treat their migraine attacks with the investigational drug during the mild pain phase and within one hour of onset of migraine head pain. You will be asked to record features of the treated migraine in a diary.
The study will determine the percentage of women who are headache pain free at 2 hours following treatment at the mild pain phase of a single menstrual migraine attack and within one hour of onset of pain with the investigational drug compared with placebo. Your participation in this study can help researchers better understand how to treat debilitating migraine attacks and other menstrual symptoms to prevent mild pain from getting worse and, as a result, causing work absenteeism and negatively affecting your time with family and friends.
For more information, or to find out if you may be eligible, please call Larry Seidman, D.O., a board certified gynecologist, at 215-676-6696.
Disclosure/Rights
Before participating in a study, the study is explained to you in detail, including the advantages and the side effects of each medication and your time commitment. You are also given a detailed consent form to read. If you desire, Dr. Seidman will notify any of your physicians about your participation.
During the course of the study, Dr. Seidman and his staff are always available to answer any questions. Your privacy is protected, and your medical records are confidential. You are free to discontinue the study at any time for any reason.
For more information, please contact Dr. Larry S. Seidman, DO, a board certified gynecologist, at 215-676-6696.
We are participating in a clinical research study evaluating the investigational form of a marketed drug compared to placebo in the treatment of menstrual migraine headaches. If you suffer from moderate to severe menstrual migraines that start with a mild pain phase, you may qualify.
To be considered for participation in this research study, you must be between the ages of 18 and 65, have had a menstrual migraine in at least 2 of the 3 premenstrual periods prior to screening, and be otherwise generally healthy. Medical staff at my site will review additional criteria with you to determine if you are eligible.
If you are eligible and decide to participate, you can expect 2 office visits: the Screening visit and the Final visit to occur either after the treatment of a single migraine attack or within 12 weeks of randomization if a headache has not been treated. All study participants will be instructed to treat their migraine attacks with the investigational drug during the mild pain phase and within one hour of onset of migraine head pain. You will be asked to record features of the treated migraine in a diary.
The study will determine the percentage of women who are headache pain free at 2 hours following treatment at the mild pain phase of a single menstrual migraine attack and within one hour of onset of pain with the investigational drug compared with placebo. Your participation in this study can help researchers better understand how to treat debilitating migraine attacks and other menstrual symptoms to prevent mild pain from getting worse and, as a result, causing work absenteeism and negatively affecting your time with family and friends.
For more information, or to find out if you may be eligible, please call Larry Seidman, D.O., a board certified gynecologist, at 215-676-6696.
Disclosure/Rights
Before participating in a study, the study is explained to you in detail, including the advantages and the side effects of each medication and your time commitment. You are also given a detailed consent form to read. If you desire, Dr. Seidman will notify any of your physicians about your participation.
During the course of the study, Dr. Seidman and his staff are always available to answer any questions. Your privacy is protected, and your medical records are confidential. You are free to discontinue the study at any time for any reason.
For more information, please contact Dr. Larry S. Seidman, DO, a board certified gynecologist, at 215-676-6696.